Navigation Links
Remove Diabetes Drug Avandia From Market: FDA Documents
Date:2/20/2010

sponsor to do long-term clinical trials to show health benefits, as a result of the failure of the FDA to insist on it, we have data that are weak."

Following on the Cleveland Clinic study, the FDA demanded "black box" warnings on labeling for both Avandia and Actos, warning of a potentially heightened risks for heart failure. However, other studies found no raised level of heart risk, and at the time the agency said it had not reached a definitive conclusion on the data.

In November of the same year, the FDA updated Avandia's labeling to include a caution regarding heart attack risk. At the time, Dr. Janet Woodcock, acting director of the FDA's Center for Drug Evaluation and Research, said that, "we are keeping Avandia on the market because we have concluded there isn't enough evidence to indicate that the risk of heart attack is higher for Avandia than other type 2 diabetes treatments."

The story got more complicated in 2008, as a number of studies emerged tying the use of Avandia to increased bone fracture risk.

Throughout 2009, more studies reiterating the drug's heart risks also came to light, including one published in the BMJ suggesting that Avandia's risk for heart failure seemed to outstrip those of its related rival, Actos.

By that point, "most clinicians [had] stopped using Avandia -- some will use Actos instead or go to another class completely," Dr. Carl J. Lavie, medical director of cardiac rehabilitation at the Ochsner Heart and Vascular Institute in New Orleans, told HealthDay at the time.

The emergence of the leaked documents on Saturday comes at a time when officials within the FDA seem to be at loggerheads over whether to ban Avandia or not, the Times reported. The newspaper said that some officials believe that safer alternatives exist, while others say the evidence on Avandia's safety is conflicted and the drug should remain available as a treatment option.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. Surgeons Remove Gallbladder Through Vagina
3. CVS/pharmacy to Remove OTC Infant Cough & Cold Products from Its Stores as Part of CHPAs Voluntary Withdrawal
4. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
5. Stop & Shop Removes Childrens Cough and Cold Medicine from Store Shelves
6. Giant Food Removes Childrens Cough and Cold Medicine From Store Shelves
7. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
8. Health Groups Call on Cosmetic Giant LOreal to Remove Lead From Lipstick
9. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
10. Nations Largest Pet Insurer Reveals Top 10 Items Surgically Removed From Pets
11. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 This two-day, advanced ... vestibular sequellae that may arise following a concussion ... concussions can be varied, from sports related injuries, car ... sustained by the thousands of returning soldiers from war ... blast and blunt traumas can result in similar injuries, ...
(Date:9/30/2014)... Amy Norton ... News) -- Long-acting contraceptive devices should be the first ... from the American Academy of Pediatrics state. Although ... pills, two other forms of contraception -- intrauterine devices ... according to the academy. And they should be ...
(Date:9/30/2014)... HealthDay Reporter , MONDAY, Sept. ... broad-spectrum antibiotics before the age of 2 may face ... new research suggests. Broad-spectrum antibiotics target a larger ... study. "It is a reason to think about ... picking," said lead researcher Dr. Charles Bailey, attending physician ...
(Date:9/30/2014)... Thompson HealthDay Reporter MONDAY, ... receive medical implants -- artificial valves, hip replacements, surgical mesh ... tested before or after their approval by the U.S. Food ... -- conducted by prominent nonprofit groups and published online Sept. ... blame for inadequate medical device testing on lax oversight by ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... provider in the nation, today announced that Adam ... Healthcare’s anesthesiology division, will present at the Society ... SHSMD Connections 2014 . The conference will ... , SHSMD Connections is a four-day conference that ...
Breaking Medicine News(10 mins):Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 2Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 3Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 2Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 3
... has announced,the appointment of Florence L. DiBenedetto as senior ... January 5, 2009, succeeding longtime,General Counsel Gary Loveridge who ... Formerly senior partner of the Sacramento-based law firm Hunter ... decades, DiBenedetto,served for more than 10 years as the ...
... Progressive Lenses and Transitions® Lenses to Produce Optimal Visual Experience ... ... Two of the most distinguished names in the optical industry are ... ,Carl Zeiss Vision, a leader for 160 years in precision optics, ...
... Dec. 17 Hologic, Inc. (Nasdaq: HOLX ), ... imaging systems and surgical products dedicated to serving the healthcare ... quarter fiscal 2009 operating results on Monday, February 2, 2009 ... host a conference call on Monday, February 2, 2009 at ...
... eggs to fertility clinics reported satisfaction with the process, ... 20 percent reported lasting psychological effects, according to the ... , The research by scientists at the University of ... 20 states and is the largest study to explore ...
... 1 Million Prescriptions , , ... wholly owned subsidiary of the Cystic Fibrosis Foundation, today announced ... cystic fibrosis (CF) community nationwide. , , ... patient, one prescription and a mission to improve access to ...
... to Meet Joint Commission Compliance through Patient Engagement , ... In an effort to improve patient safety and standards ... Patient Care (IPC) solutions, is enabling King,s Daughters Medical Center ... Patient Safety Goal (NPSG) 16 through GetWellNetwork,s interactive PatientLife ...
Cached Medicine News:Health News:Sutter Health Welcomes New General Counsel 2Health News:Carl Zeiss Vision and Transitions Optical Inc. Promote Pioneering Eyewear to Consumers 2Health News:Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009 2Health News:Most women report satisfaction with egg donation; some claim problems 2Health News:Most women report satisfaction with egg donation; some claim problems 3Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 3
(Date:9/29/2014)... N.Y. and PARIS , ... REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today ... an investigational therapy that blocks IL-4 and IL-13 signaling, ... moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did ... data suggest the potential of dupilumab for use in ...
(Date:9/29/2014)... ORLANDO, Fla. and DUBLIN ... TNIB) ("we" or the "Company"), a biotechnology company pioneering ... the marketing of innovative therapies for cancer, HIV/AIDS, opportunistic ... letter to its shareholders from CEO Noreen Griffin The ... BioTech, Inc. (the "Company" or "TNIB") received a number ...
(Date:9/29/2014)... 2014  Bob Pack, who lost his two young ... California Medical Association to immediately cease airing a television ... Jose Mercury News called "shamelessly deceptive" and of which ... to believe about the measure is wrong." ... requirement that doctors check California,s ...
Breaking Medicine Technology:Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 2Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 3Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 4Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 6Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5
... 20 In an effort to ... supply chain, Siemens Healthcare Diagnostics (Siemens) has published product data ... U.S. product line into the GHX Health ConneXion(SM) data pool. ... GS1,s Global Data Synchronization Network (GDSN®) that is focused solely ...
... Kinetic Systems, Inc., a leading global provider of process ... clients, announced today the appointment of Peter M. Maris ... to its Board of Directors. He will also continue ... Mr. Maris has been with Kinetics for more than ...
Cached Medicine Technology:Siemens Healthcare Diagnostics Publishes Global Trade Item Numbers (GTINs) for its Entire U.S. Product Line to the GHX Health ConneXion(SM) Data Pool 2Siemens Healthcare Diagnostics Publishes Global Trade Item Numbers (GTINs) for its Entire U.S. Product Line to the GHX Health ConneXion(SM) Data Pool 3Kinetic Systems Appoints Peter M. Maris President & Chief Executive Officer 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
Inquire...
Inquire...
Medicine Products: